Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 3.99 M3.71 M3.59 M3.4 M3.91 M4.29 M 15.19 M Research & development 13.01 M12.61 M11.91 M10.72 M11.71 M12.61 M 46.95 M Operating income -17 M-16.32 M-15.5 M-14.13 M-15.62 M-16.9 M -62.14 M Non-Operating Income, Total —————— — Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income -17 M-16.32 M-15.5 M-14.13 M-15.62 M-16.9 M -62.14 M Equity in earnings —————— — Taxes ———0—— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -15.93 M-15.39 M-14.7 M-13.5 M-15.16 M-15.35 M -58.7 M Discontinued operations —————— — Net income -15.93 M-15.39 M-14.7 M-13.5 M-15.16 M-15.35 M -58.7 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -15.93 M-15.39 M-14.7 M-13.5 M-15.16 M-15.35 M -58.7 M Basic earnings per share (Basic EPS) -1.19-1.14-1.09-0.98-1.11-0.31 -3.49 Diluted earnings per share (Diluted EPS) -1.19-1.14-1.09-0.98-1.11-0.31 -3.49 Average basic shares outstanding 13.42 M13.51 M13.53 M13.52 M13.67 M49.87 M — Diluted shares outstanding 13.42 M13.51 M13.53 M13.52 M13.67 M49.87 M — EBITDA -15.81 M-15.27 M-14.59 M-13.4 M-15.05 M-15.26 M -58.3 M EBIT -15.93 M-15.39 M-14.7 M-13.5 M-15.16 M-15.35 M -58.7 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 118 K117 K108 K104 K104 K87 K 403 K